<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE resolution PUBLIC "-//US Congress//DTDs/res.dtd//EN" "res.dtd">
<resolution public-private="public" resolution-stage="Introduced-in-Senate" resolution-type="senate-resolution">
	<form>
		<distribution-code display="yes">III</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. RES. 307</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20070905">September 5, 2007</action-date>
			<action-desc><sponsor name-id="S305">Mr. Isakson</sponsor> (for himself
			 and <cosponsor name-id="S297">Mr. Salazar</cosponsor>) submitted the following
			 resolution; which was referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and
			 Pensions</committee-name></action-desc>
		</action>
		<legis-type>RESOLUTION</legis-type>
		<official-title display="yes">Supporting efforts to increase childhood
		  cancer awareness, treatment, and research.</official-title>
	</form>
	<preamble>
		<whereas><text>Whereas an estimated 12,400 children are diagnosed with
			 cancer each year;</text>
		</whereas><whereas><text>Whereas cancer is the leading cause of death by disease in
			 children under age 15;</text>
		</whereas><whereas><text>Whereas an estimated 2,300 children die from cancer each
			 year;</text>
		</whereas><whereas><text>Whereas the incidence of cancer among children in the
			 United States is rising by about 1 percent each year;</text>
		</whereas><whereas><text>Whereas 1 in every 330 people in the United States
			 develops cancer before age 20;</text>
		</whereas><whereas><text>Whereas approximately 8 percent of deaths of individuals
			 between 1 and 19 years old are caused by cancer;</text>
		</whereas><whereas><text>Whereas, while some progress has been made, a number of
			 opportunities for childhood cancer research still remain unfunded or
			 underfunded;</text>
		</whereas><whereas><text>Whereas limited resources for childhood cancer research
			 can hinder the recruitment of investigators and physicians to field of
			 pediatric oncology;</text>
		</whereas><whereas><text>Whereas the results of peer-reviewed clinical trials have
			 helped to raise the standard of care for pediatrics and have improved cancer
			 survival rates among children;</text>
		</whereas><whereas><text>Whereas the number of survivors of childhood cancers
			 continues to increase, with about 1 in 640 adults between ages 20 to 39 having
			 a history of cancer;</text>
		</whereas><whereas><text>Whereas up to <fraction>2/3</fraction> of childhood cancer
			 survivors are likely to experience at least 1 late effect from treatment, which
			 may be life-threatening;</text>
		</whereas><whereas><text>Whereas some late effects of cancer treatment are
			 identified early in follow-up and are easily resolved, while others may become
			 chronic problems in adulthood and have serious consequences; and</text>
		</whereas><whereas><text>Whereas 89 percent of children with cancer experience
			 substantial suffering in the last month of life: Now, therefore, be it</text>
		</whereas></preamble>
	<resolution-body>
		<section display-inline="yes-display-inline" id="H05C8AEB4892842BCB80062915FBE01BD" section-type="undesignated-section"><enum></enum><text>That it is the sense of Senate that
			 Congress should support—</text>
			<paragraph id="H81588C5C8A584494B0E03D87E0E14F39"><enum>(1)</enum><text>public and private
			 sector efforts to promote awareness about—</text>
				<subparagraph id="id9485F202E70D4D9995D8F63689FC9618"><enum>(A)</enum><text>the incidence of
			 cancer among children;</text>
				</subparagraph><subparagraph id="id55DFF57E7ACB42B2835C945AA125D73D"><enum>(B)</enum><text>the signs and
			 symptoms of cancer in children;</text>
				</subparagraph><subparagraph id="id1485A4A5DA92435295601AA211DBE843"><enum>(C)</enum><text>options for the
			 treatment of, and long-term follow-up for, childhood cancers;</text>
				</subparagraph></paragraph><paragraph id="H4CD408F5F35049B3BAC8704B6C944651"><enum>(2)</enum><text>increased public
			 and private investment in childhood cancer research to improve prevention,
			 diagnosis, treatment, rehabilitation, post-treatment monitoring, and long-term
			 survival;</text>
			</paragraph><paragraph id="H5FE9A0DBFACA4FA995E28BFFB6908F39"><enum>(3)</enum><text>policies that
			 provide incentives to encourage medical trainees and investigators to enter the
			 field of pediatric oncology;</text>
			</paragraph><paragraph id="HA323C646C1BE4E988ED33703C0AD7906"><enum>(4)</enum><text>policies that
			 provide incentives to encourage the development of drugs and biologics designed
			 to treat pediatric cancers;</text>
			</paragraph><paragraph id="HAA5F6A4AFD6A406A92D73D9F00CE6D50"><enum>(5)</enum><text>policies that
			 encourage participation in clinical trials;</text>
			</paragraph><paragraph id="HF541FDA2172C4E6983DA3D80EBF32835"><enum>(6)</enum><text>medical education
			 curricula designed to improve pain management for cancer patients; and</text>
			</paragraph><paragraph id="H99857CECAA7A4E96B6AB681D92B779F"><enum>(7)</enum><text display-inline="yes-display-inline">policies that enhance education, services,
			 and other resources related to late effects from treatment.</text>
			</paragraph></section></resolution-body>
</resolution>
